2؉ levels is known to play a key role in the pathological events following cerebral ischemia. DY-9760e, 3-[2-[4-(3-chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, is a potent calmodulin antagonist that attenuates brain damage in focal ischemia models. In the present study, we investigated the effect of DY-9760e on neuronal cell death induced by a variety of cell-toxic stimuli that increase intracellular Ca 
levels are considered to be implicated in the pathogenesis of ischemic brain injury. [1] [2] [3] [4] It is proposed that the elevation of intracellular Ca 2ϩ levels can be brought about by a massive influx of extracellular Ca 2ϩ through voltage-gated 1, 5) or agonist-activated channels, 2, 6, 7) and a release of Ca 2ϩ from intracellular store sites such as endoplasmic reticulum (ER) and mitochondria. [8] [9] [10] Excessive elevation of Ca 2ϩ in neurons disrupts the ionic balance and activates various Ca 2ϩ -dependent enzymes.
Calmodulin is a major Ca 2ϩ -binding protein found mainly in the central nervous system, and it is implicated in a variety of physiological cell functions through the activation of calmodulin-dependent enzymes, such as phosphodiesterase, protein kinases, phosphatase, and nitric oxide synthase (NOS). 11, 12) Ca 2ϩ overload into neurons induced by ischemic insult may therefore aberrantly activate Ca 2ϩ /calmodulindependent pathways and lead to irreversible cell damage. Indeed, it has been previously reported that a persistent increase in the concentration of Ca 2ϩ -bound calmodulin, which is an active form of calmodulin, is associated with ischemic neuronal damage. 13) Furthermore, calmodulin antagonists have been shown to protect against hypoxia/hypoglycemia in organic hippocampal cultures. 14) We have developed a competitive calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenylmethyl)-1-piperazinyl]-ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), which exerts a cytoprotective action against the cell death induced by a Ca 2ϩ ionophore 15) and ameliorates brain injury that occurs after transient and permanent focal ischemia in rats. [16] [17] [18] [19] Since DY-9760e does not alter cerebral blood flow (CBF) following focal ischemia, 17) it may produce the neuroprotection against cerebral ischemia via mechanisms other than the improvement of CBF. To further clarify the neuroprotective properties of DY-9760e, using rat primary cultured neurons, we evaluated the effect of the drug on the neuronal cell death elicited by cell-toxic stimuli that mimic cellular events observed in cerebral ischemia. We show here that DY-9760e rescues neurons from cell death resulting from excitotoxicity, membrane-depolarization, and inhibition of ER Ca 2ϩ -ATPase. Neuronal Cultures Primary cortical neurons were cultured from embryonic day 17-18 rat fetuses as described previously. 20) Neurons were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with B27 serum replacement (Invitrogen, Carlsbad, CA, U.S.A.). The neurons were plated onto 96-well polyethyleneimine-coated culture plates at a density of 30000 cells/well. Experiments were performed after the neurons were cultured for 10 d.
MATERIALS AND METHODS

Materials
Cell Death Assay The experiments were carried out in DMEM containing B27 supplement. DY-9760e was dissolved in 50 mM Sörensen buffer (pH 4.5), which was prepared from 50 mM glycine and 50 mM sodium chloride adjusted for pH with 1 N HCl, and applied to the cells 1 h prior to the treatment with various cell-death inducers. The neuronal cultures were subsequently exposed to toxic agents under the following conditions: 50 mM glutamate for 10 min; 100 mM NMDA for 15 min; 10 mM veratridine for 24 h; 90 mM KCl for 30 min; or 100 nM thapsigargin for 24 h. Cell death was assessed by measuring the amount of lactate dehydrogenase (LDH) leaked from the cells into the culture media with the MTX LDH kit (Kyokuto Pharmaceutical Industrial, Tokyo, Japan) 24 h after application of the cell death inducers. In preliminary experiments, LDH leakage from cells exposed to 100 mM NMDA, 10 mM veratridine or 90 mM KCl was approximately 37, 31 or 44% of the total LDH content, respectively. The data of the present study were presented as percentages of LDH activity compared with the control (without any agents). None of the concentrations of DY9760e used in this study affected the basal levels of LDH (data not shown). Results were expressed as the meansϮ S.E.M. and analyzed for statistical significance by one-way analysis of variance followed by Dunnett's test. The difference was considered significant if the p value was less than 0.05.
RESULTS
DY-9760e Protects Neurons from Excitotoxicity
Following cerebral ischemia, the release of excess glutamate into the extracellular space triggers the opening of cationpermeable channels at NMDA receptor followed by Ca 2ϩ influx into neurons. [1] [2] [3] [4] We first investigated whether DY-9760e protects against neuronal cell death induced by glutamate and NMDA. The incubation of cortical neurons with 50 mM glutamate for 10 min caused significant neuronal cell death, as determined by LDH leakage from the neurons 24 h after the application (Fig. 1A) . DY-9760e reduced the LDH leakage by 30, 50, 60 and 85% at the concentrations of 0.01, 0.1, 1 and 10 mM, respectively (Fig. 1A) . In addition, DY-9760e dose-dependently prevented the LDH leakage from cells 24 h after exposure to 100 mM NMDA for 15 min (Fig. 1B) . These results indicate that DY-9760e protects against excitotoxic neuronal cell death.
DY-9760e Protects against Neuronal Cell Death Induced by Voltage-Gated Channel Opening Neuronal cell damage is initiated by not only the entry of Ca 2ϩ through glutamate receptors, as described above, but also Ca 2ϩ influx through voltage-sensitive channels upon membrane depolarization. 1, 5) To determine the effect of DY-9760e on cell death caused by the activation of voltage-sensitive channels, we used two different membrane-depolarizing agents, veratridine and high KCl, that allow not only Na ϩ , but also Ca 2ϩ to enter into the cytoplasm through these channels. [21] [22] [23] Exposure of neurons to 10 mM veratridine for 24 h increased LDH leakage up to approximately 4.1-fold above that in the control; this leakage was significantly inhibited by treatment with DY-9760e at concentrations of 0.01-10 mM (Fig. 2A) . Similarly, treatment with DY-9760e resulted in a dose-dependent (1-10 mM) reduction in LDH leakage from cells exposed to 90 mM KCl for 30 min (Fig. 2B) . Thus, these data suggest that DY-9760e can protect neurons from cell death mediated by the activation of voltage-gated channels in response to membrane depolarization.
DY-9760e Inhibits Neuronal Cell Death Induced by Release of Sequestered Intracellular Ca
2؉
To explore the possibility that DY-9760e provides neuroprotection through intracellular sites of action, we treated neurons with thapsigargin, a compound that is known to cause an increase in cytosolic Ca 2ϩ by blocking the ER calcium pump, Ca 2ϩ -ATPase. 24) As shown in Fig. 3 , the incubation with 100 nM thapsigargin for 24 h led to neuronal cell death, and DY-9760e (0.1-10 mM) significantly blocked thapsigargininduced cell death in a dose dependent manner.
DISCUSSION
We have previously reported that DY-9760e, a potent calmodulin antagonist, reduces the cerebral infarct volume and brain edema after transient and permanent focal ischemia in rats. [16] [17] [18] [19] In this report, we provide evidence that DY-9760e can rescue neurons against cell death resulting from excitotoxicity, membrane-depolarization, and inhibition of ER Ca 2ϩ -ATPase, all of which are known to increase intracellular Ca 2ϩ . It is widely accepted that an excessive elevation of intracellular Ca 2ϩ concentration plays a major role in ischemic Cortical neurons were pretreated with DY-9760e for 1 h and then were exposed to 50 mM glutamate for 10 min (A) or 100 mM NMDA for 15 min (B). The extent of cell death was assayed by LDH leakage from the neurons 24 h after application of stimulants. Data represent meansϮS.E.M. (nϭ6, glutamate-induced cell death; nϭ10, NMDA-induced cell death). * pϽ0.05, significantly different from glutamate alone. Neurons were pretreated with DY-9760e for 1 h, and then 100 nM thapsigargin was added to the cells and incubated for 24 h. Cell death was assayed as described in Fig. 1 cell injury in neurons. 1, 2, 4, 26) This increase is mainly caused by the influx of extracellular Ca 2ϩ through receptor-operated 2, 6, 7) or voltage-gated channels, 1, 5) and the release of sequestered Ca 2ϩ from ER and mitochondria. [8] [9] [10] Glutamate, a major excitatory neurotransmitter in the central nervous system, is a potential toxin leading to excitotoxicity when it is over-accumulated in the extracellular space.
2) Glutamate-induced excitotoxicity is associated with an excessive influx of Ca 2ϩ mainly via the NMDA receptor of glutamate. 26 ) Some Ca 2ϩ has been shown to enter through a-amino-3-hydroxy-5-methyl-4-isoxazolepropinate (AMPA)/ kinate receptor-gated channels in cultured neurons. 27, 28) In addition to excitotoxicity, voltage-gated channel opening induced by veratridine, the voltage-sensitive Na ϩ channel activator, or high KCl, also causes neuronal cell death, which is brought about by massive Ca 2ϩ influx. [21] [22] [23] In this study, we found that DY-9760e protects neurons from cell death induced both by excitotoxicity with glutamate or NMDA and by activation of voltage-gated channels with veratridine or high KCl. Furthermore, the drug prevented a reduction in cell viability after exposure to thapsigargin, a specific inhibitor of ER Ca 2ϩ -ATPase that mobilizes Ca 2ϩ from intracellular stores. 24) Thus, these results indicate that DY-9760e is protective against neurotoxicity elicited not only by influx of extracellular Ca 2ϩ through voltage-gated channels or glutamate receptors but also by release of sequestered intracellular Ca 2ϩ and suggest the possibility of an intracellular site of action.
There is evidence that calmodulin plays a critical role in ischemic brain injury as follows: 1) a persistent increase of Ca 2ϩ -bound calmodulin, which is an active form, after ischemic insults 13) ; 2) significant up-regulation of calmodulin gene expression in the CA1 pyramidal cell layer after cerebral ischemia 29) ; 3) protection by calmodulin antagonists against hypoxic/hypoglycemia in organotypic hippocampal cultures 14) ; and 4) reduction in transient focal ischemiainduced brain injury by treatment with trifluoperazine, a calmodulin antagonist that is structurally different from DY9760e. 18, 30) DY-9760e has been shown to prevent Ca 2ϩ ionophore-induced cell death in neuroblastoma cells with a more potent protective effect than that of W-7, a well-known calmodulin antagonist. 15) Given the protection shown by DY-9760e against a variety of cell-death inducers, it is plausible that the amelioration of ischemic brain injury with this drug is mediated by calmodulin antagonistic action. Furthermore, with respect to calmodulin-mediated cell death, there are several intriguing reports: 1) PEP-19, a brain-specific protein and negative regulator of calmodulin, can inhibit apoptotic processes in PC12 cells following UV irradiation or staurosporine treatment 31) ; and 2) immunoreactivity for PEP-19 is dramatically reduced in the brains from patients with Alzheimer's and Huntington's disease. 32) These data indicate that calmodulin may also contribute to neuronal loss in neurodegenerative diseases.
Calmodulin is implicated in a variety of cell functions by its interactions with various calmodulin-binding proteins. 11, 12) Among them, fodrin, a cytoskeletal protein lying under the plasma membrane in neurons, is degraded by calpain, a Ca 2ϩ -dependent protease, after cerebral ischemia, thereby leading to membrane damage and finally cell death. [33] [34] [35] Interestingly, it is reported that calmodulin facilitates the proteolytic degradation of fodrin by calpain, [36] [37] [38] suggesting a role for calmodulin in regulating proteolysis by calpain. DY-9760e, which exerts no direct action on calpain, can indeed inhibit the degradation of fodrin after transient focal ischemia. 15, 16) Furthermore, intracellular Ca 2ϩ overload after ischemic insult may induce the sustained activation of Ca 2ϩ /calmodulin-dependent enzymes, such as NOS, [39] [40] [41] [42] [43] calcineurin, [44] [45] [46] death-associated protein kinase, 47) and calmodulin kinase II (CaMKII), 21, 48) leading to irreversible cell damage. We have also demonstrated that DY-9760e inhibits not only purified neuronal NOS activity most potently but also NO production after exposure of neuroblastoma cells to Ca 2ϩ ionophore 49) and cerebral ischemia/reperfusion in gerbils.
50) The neuroprotection of DY-9760e may, therefore, be mediated at least in part by inhibition of NO production and fodrin degradation. Based on previous observations, together with present findings, we propose a scheme for the mechanism by which DY-9760e may exert neuroprotection by blocking Ca 2ϩ /calmodulin-dependent pathways (Fig. 4) .
In conclusion, DY-9760e can rescue neurons from various types of cell-toxic stimuli that increase intracellular Ca 2ϩ . Although further investigations are required to address which Ca 2ϩ /calmodulin-dependent pathways play critical roles in inducing neuronal cell death, the protection of DY-9760e is likely to be mediated by blocking several Ca 2ϩ /calmodulindependent pathways. Thus, drugs that inhibit aberrant activation of calmodulin-dependent pathways may have a therapeutic effect in the acute phase of cerebral ischemic damage. /calmodulin-dependent pathways and finally lead to neuronal cell death. Considering the fact that DY-9760e is protective against various types of celltoxic stimuli, its effect may be mediated by a calmodulin antagonistic action.
